MCM
DXCM icon

Manchester Capital Management’s DexCom DXCM Stock Holding History

Manchester Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Buy
159
+11
+7% +$733 ﹤0.01% 787
2026
Q1 		$9.29K Hold
148
– – ﹤0.01% 800
2025
Q4 		$9.82K Sell
148
-32
-18% -$2.07K ﹤0.01% 785
2025
Q3 		$12.1K Buy
180
+36
+25% +$2.85K ﹤0.01% 843
2025
Q2 		$12.6K Sell
144
-1
-0.7% -$78 ﹤0.01% 796
2025
Q1 		$9.9K Sell
145
-9
-6% -$734 ﹤0.01% 819
2024
Q4 		$12K Buy
154
+21
+16% +$1.55K ﹤0.01% 787
2024
Q3 		$8.92K Buy
133
+45
+51% +$3.69K ﹤0.01% 819
2024
Q2 		$9.98K Buy
88
+9
+11% +$1.14K ﹤0.01% 759
2024
Q1 		$11K Buy
79
+17
+27% +$2.14K ﹤0.01% 623
2023
Q4 		$7.69K Buy
62
+54
+675% +$5.52K ﹤0.01% 643
2023
Q3 		$747 Hold
8
– – ﹤0.01% 863
2023
Q2 		$1.03K Buy
+8
New +$968 ﹤0.01% 807
2021
Q1 		– Sell
-12
Closed -$1K – 677
2020
Q4 		$1K Buy
+12
New +$1.07K ﹤0.01% 646
2015
Q1 		– Sell
-21,452
Closed -$295K – 627
2014
Q4 		$295K Buy
+21,452
New +$263K 0.04% 266

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Manchester Capital Management's DXCM Position: Q2 2026 in Review

Manchester Capital Management increased its DexCom (DXCM) stake by 7.4% in Q2 2026, buying an estimated $733 and bringing the position to 159 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Manchester Capital Management first reported a position in DXCM in Q4 2014 and has held it in 15 quarters since. The position peaked at $295K in Q4 2014. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Manchester Capital Management held 159 shares of DexCom worth $10.7K as of Q2 2026.
  • Manchester Capital Management bought 11 DexCom shares in Q2 2026, an estimated $733.
  • DexCom made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #787 holding.
  • Manchester Capital Management first reported a position in DexCom in Q4 2014 and has held it in 15 quarters since.
  • Manchester Capital Management's DexCom position peaked at $295K in Q4 2014.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.